- Results showed comparable improvement in joint contracture and range of motion to single injection in previous studies - This study was conducted by BioSpecifics' partner Auxilium Pharmaceuticals, ...
Auxilium Pharmaceuticals (AUXL) Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p < 0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture XIAFLEX Also Meets ...
Common activities for patients with Dupuytren's such as those at the workplace (eg, manual labor, wearing gloves) or at home (eg, washing, dressing) can be signicantly affected, posing a threat to ...
DUBLIN, June 5, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that post-hoc data from two Phase 3 studies of XIAFLEX ® (collagenase clostridium histolyticum, or CCH, ...
XIAFLEX (collagenase clostridium histolyticum) 0.5mg for injection Auxilium Pharmaceuticals announced new data from its Phase 3 IMPRESS trials that evaluated Xiaflex for the treatment of Peyronie's ...
MALVERN, Pa., Feb. 3 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), a specialty biopharmaceutical company, just announced that it has received marketing approval from the U.S. Food and ...
DUBLIN, Jan. 24, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that the peer-reviewed Journal of Hand Surgery Global Open published Collagenase Clostridium Histolyticum for ...
-- Endo presents encore data of research evaluating the impact of PD on erectile function and female partners, as well as the efficacy of XIAFLEX® treatment -- DUBLIN, May 19, 2015 /PRNewswire/ -- ...
LAFAYETTE, LA--(Marketwired - Sep 17, 2014) - Introducing Xiaflex®, a revolutionary treatment utilized by Dr. Jeffrey S. Williams of Plastic Surgery Associates in Lafayette, LA. This advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback